WebAtlanta (Sept. 30, 2024) – Clinicians at Piedmont Heart Institute at Piedmont Atlanta Hospital performed the first HighLife Trans-septal Mitral Valve Replacement (TSMVR) in the United States on July 13, 2024, as part of an early feasibility trial.. This innovative technique is used to treat patients with mitral valve insufficiency or regurgitation using a minimally … WebWatch this session presented by Didier Tchetche in order to learn about the HighLife transseptal mitral valve replacement study status, to understand the complex patient population treated and first outcomes, and to be familiar with the current technology and future enhancements. ... (TSMVR): clinical study update Sponsored by HighLife.
HIGHLIFE Trans-Septal Mitral Valve Replacement (TSMVR) - YouTube
WebMay 21, 2024 · 8.73K subscribers Watch this session presented by Wolfgang Rottbauer in order to learn about the HighLife transseptal mitral valve replacement procedure, to … Web公司引入的 HighLife TSMVR 已于2024 年 11 月启动注册性临床,该产品将瓣膜与锚定环分离,有助于减轻瓣周漏的风险,并有效缩小导管的尺寸。我们预计该产品将于 2025E 获批上市,也是公司首款获批上市的二尖瓣产品。 how do i get a tpi number
HighLife TSMVR and their latest experiences, moving forward
http://www.highlifemedical.com/ WebTo understand HighLife's solutions to common challenges (LVOTO and large anatomies) addressed by innovative mitral valve designs. To be informed about the latest clinical data and future clinical studies towards regulatory approval for the Highlife Transeptal Mitral Valve … WebMay 22, 2024 · The Millipede IRIS Mitral Annuloplasty System™ (Boston Scientific, Massachuetts, USA) is a transfemoral, transeptal system delivered through a 24 Fr deflectable catheter. The device is a semi-rigid complete nitinol ring with a zig-zag configuration and 8 helical stainless-steel anchors at its base. how much is the energy credit